First Light Asset Management »

Xenon Pharmaceuticals shares owned by First Light Asset Management

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $76M 1.6M 46.06
2023-09-30 $21M 602k 34.16
2023-06-30 $13M 339k 38.50
2023-03-31 $10M 279k 35.79

More positions owned by First Light Asset Management

Karuna Therapeutics Common Stocks
Alphatec Holdings Common Stocks (ATEC)
Xenon Pharmaceuticals Common Stocks (XENE)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Pliant Therapeutics Common Stocks (PLRX)
Neogenomics Common Stocks (NEO)
Transmedics Group Common Stocks (TMDX)
Si-bone Common Stocks (SIBN)
Atricure Common Stocks (ATRC)
Paragon 28 Common Stocks (FNA)
Model N Common Stocks (MODN)
Tactile Systems Technology Common Stocks (TCMD)
Prothena Corporation Common Stocks (PRTA)
Ultragenyx Pharmaceutical Common Stocks (RARE)
Performant Financial Corporation Common Stocks (PFMT)

View all positions for First Light Asset Management

Top funds holding Xenon Pharmaceuticals

venBio Select Advisor
Wellington Management Company
Commodore Capital
Paradigm Biocapital Advisors
Braidwell
First Light Asset Management
Alliancebernstein
Marshall Wace
Citadel Advisors
Perceptive Advisors
Baker Bros. Advisors
Henderson Group
BVF
Point72 Asset Management
Avidity Partners Management

View all funds holding Xenon Pharmaceuticals